Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Clene Inc.CLNN · Entity 7166 | Chief Science Officer | June 11, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Clene Inc.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $5.53 · Expires 2036-06-10 | Direct | 45,000 |
Reported balance
After 2026-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 45,000 · Balance 45,000 F1: This option was granted on June 11, 2026 as an option for 45,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on June 11, 2026 as an option for 45,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 15, 2026 18:24 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 45,000 | $0.00 Strike: $5.53 | $0.00 |
DisclosureSEC source: 0001437749-26-020637 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: common stock · 45,000 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 11, 2026 as an option for 45,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 21:14 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 75,000 | $0.00 Strike: $5.42 | $0.00 |
DisclosureSEC source: 0001437749-26-001912 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: common stock · 75,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: This option was granted on January 22, 2026 as an option for 75,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant. Read SEC document |
| September 25, 2025 Filed Sep 29, 2025 20:13 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 40,000 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0001437749-25-030019 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: common stock · 40,000 shares Expires 2035-09-24 F1 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.05 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 25, 2025 Filed Sep 30, 2025 19:59 UTC Amendment | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 40,000 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001437749-25-030109 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: common stock · 40,000 shares Expires 2035-09-24 F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on September 29, 2025. The corrected exercise price is $5.88 per share. F2 · derivative.exercise_date: This option was granted on September 25, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.88 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 19:48 UTC | Clene Inc. CLNN · Entity 7166 | Grantstock option · Derivative | 10,000 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001437749-25-029474 · rdgdoc.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: common stock · 10,000 shares Expires 2035-09-17 F1 · derivative.exercise_date: This option was granted on September 18, 2025 as an option for 10,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.32 per share. The options vest immediately upon grant. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 21:09 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 40,000 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-25-001591 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2035-02-23 F1 · derivative.exercise_date: This option was granted on February 24, 2025 as an option for 40,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.23 per share. The options vest with respect to the first 25% of such shares on February 24, 2026 and then in 36 equal installments of the balance of the shares of Common Stock on the 24th day of each calendar month thereafter beginning March 24, 2026 until such shares are fully vested. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:17 UTC | Clene Inc. CLNN · Entity 7166 | GrantWarrants (Right to buy) · Derivative | 20,512 | $0.13 Strike: $4.82 | $2,564.00 |
DisclosureSEC source: 0001562180-24-007038 · primarydocument.xml · derivative · entry 2 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,512 Underlying: Common Stock · 20,512 shares Expires 2029-10-01 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:17 UTC | Clene Inc. CLNN · Entity 7166 | PurchaseCommon Stock | 20,512 | $4.75 | $97,432.00 |
DisclosureSEC source: 0001562180-24-007038 · primarydocument.xml · nonDerivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,949 F1 · balance_after: On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's previously owned 168,759 shares of common being reduced to 8,437 shares of common stock. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 20:21 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 25,000 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0001562180-24-006356 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-08-15 F1 · derivative.exercise_date: This option was granted on August 16, 2024 as an option for 25,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.15 per share. The options vest with respect to 1/12th of such shares on September 16, 2024 and then an additional 1/12th of such options vest on the 16th day of each calendar month thereafter until such shares are fully vested. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:17 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 800,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001562180-24-004899 · primarydocument.xml · derivative · entry 2 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-06-06 F2 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 800,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 25% of such shares on June 7, 2025 and then in 36 equal installments of Common Stock on the 7th day of each calendar month, beginning July 7, 2025, until such shares are fully vested Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:17 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,000,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001562180-24-004899 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 2,000,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 33.3% of such shares if Clene Inc. has an NDA accepted by the FDA, an additional 33.3% of such shares if Clene Inc. has an NDA approved by the FDA, and the remaining 33.4% of such shares if Clene Inc. achieves $100,000,000 in revenues in connection with the sales of any approved drugs. Read SEC document |
| June 29, 2023 Filed Jul 3, 2023 17:49 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 800,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001562180-23-005628 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2033-06-29 F1 · derivative.exercise_date: This option was granted on June 29, 2023 as an option for 800,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.90 per share. The options vest with respect to the first 25% of such shares on June 29, 2024 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month beginning July 29, 2024 until such shares are fully vested. If Clene Inc. has an NDA accepted by the FDA, 50% of the option shares shall vest on that date. If the FDA approves the accepted NDA, the then remaining unvested option shares shall vest on that date. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:15 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 75,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001562180-23-001572 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-17 F1 · derivative.exercise_date: This option was granted on February 17, 2023 as an option for 75,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.28 per share. The options vest in full on August 17, 2023. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 22:49 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 400,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001562180-22-007532 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2032-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2022 as an option for 400,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.11 per share. The options vest with respect to the first 25% of such shares on November 4, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 4th day of each calendar month thereafter beginning December 4, 2023 until such shares are fully vested. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 19:33 UTC | Clene Inc. CLNN · Entity 7166 | SaleCommon Stock | 20,247 | $2.47 | $50,010.09 |
DisclosureSEC source: 0001562180-22-005181 · primarydocument.xml · nonDerivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,759 F1 · shares: The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Mortenson to satisfy tax withholding obligations in connection with the vesting of 50,082 restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 14:07 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 200,000 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001562180-22-001502 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: This option was granted on February 15, 2022 as an option for 200,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month beginning March 15, 2023 until such shares are fully vested. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:14 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 200,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006878 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 200,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 13:20 UTC | Clene Inc. CLNN · Entity 7166 | GrantCommon Stock | 50,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004606 · primarydocument.xml · nonDerivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,082 F1 · shares: This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 21:26 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 200,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003066 · primarydocument.xml · derivative · entry 1 Mortenson Mark · CIK 0001835427 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-04-30 F1 · shares: This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested F1 · derivative.exercise_date: This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.